Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 24 results.
User Information
Export Records
  1. 1.   Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective
  2. Basudhar,Debashree; Bharadwaj, Gaurav; Somasundaram,Veena; Cheng,Robert; Ridnour,Lisa; Fujita, Mayumi; Lockett,Stephen; Anderson,Steve; McVicar,Daniel; Wink,David
  3. British Journal of Pharmacology. 2019, Jan; 176(2): 155-176.
  1. 2.   ERBIN deficiency links STAT3 and TGF-beta pathway defects with atopy in humans
  2. Lyons, J. J.; Liu, Y.; Ma, C. A.; Yu, X.; O'Connell, M. P.; Lawrence, M. G.; Zhang, Y.; Karpe, K.; Zhao, M.; Siegel, A. M.; Stone, K. D.; Nelson, C.; Jones, Nina; DiMaggio, T.; Darnell, D. N.; Mendoza-Caamal, E.; Orozco, L.; Hughes, J. D.; McElwee, J.; Hohman, R. J.; Frischmeyer-Guerrerio, P. A.; Rothenberg, M. E.; Freeman, A. F.; Holland, S. M.; Milner, J. D.
  3. JOURNAL OF EXPERIMENTAL MEDICINE. 2017, 2017-03-01; 214(3): 669-680.
  1. 3.   Immunological monitoring of the tumor immunoenvironment for clinical trials
  2. Malyguine, A. M.; Strobl, S. L.; Shurin, M. R.
  3. Cancer Immunology Immunotherapy. 2012, Feb; 61(2): 239-247.
  1. 4.   Highlights of 10 years of immunology in Nature Reviews Immunology
  2. Medzhitov, R.; Shevach, E. M.; Trinchieri, G.; Mellor, A. L.; Munn, D. H.; Gordon, S.; Libby, P.; Hansson, G. K.; Shortman, K.; Dong, C.; Gabrilovich, D.; Gabrysova, L.; Howes, A.; O'Garra, A.
  3. Nature Reviews Immunology. 2011, Oct; 11(10): 693-702.
  1. 5.   Nitric oxide and redox mechanisms in the immune response
  2. Wink, D. A.; Hines, H. B.; Cheng, R. Y. S.; Switzer, C. H.; Flores-Santana, W.; Vitek, M. P.; Ridnour, L. A.; Colton, C. A.
  3. Journal of Leukocyte Biology. 2011, Jun; 89(6): 873-891.
  1. 6.   At 17, In-10's Passion Need Not Inflame
  2. Stewart, C. A.; Trinchieri, G.
  3. Immunity. 2011, Apr; 34(4): 460-462.
  1. 7.   Hypoxia Potentiates Glioma-Mediated Immunosuppression
  2. Wei, J.; Wu, A.; Kong, L. Y.; Wang, Y. T.; Fuller, G.; Fokt, I.; Melillo, G.; Priebe, W.; Heimberger, A. B.
  3. Plos One. 2011, Jan; 6(1): 12.
  1. 8.   Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
  2. Shurin, M. R.; Gregory, M.; Morris, J. C.; Malyguine, A. M.
  3. Expert Opinion on Biological Therapy. 2010, Nov; 10(11): 1539-1553.
  1. 9.   Serum Cytokine Analysis in a Positive Chemoprevention Trial: Selenium, Interleukin-2, and an Association with Squamous Preneoplastic Disease
  2. Roth, M. J.; Katki, H. A.; Wei, W. Q.; Qiao, Y. L.; Bagni, R.; Wang, G. Q.; Whitby, D.; Dong, Z. W.; Gail, M. H.; Limburg, P. J.; Giffen, C. A.; Taylor, P. R.; Dawsey, S. M.
  3. Cancer Prevention Research. 2010, Jul; 3(7): 810-817.
  1. 10.   Adaptive control of innate immunity
  2. Shanker, A.
  3. Immunology Letters. 2010, Jul; 131(2): 107-112.
  1. 11.   Cancer and Inflammation: Promise for Biologic Therapy
  2. Demaria, S.; Pikarsky, E.; Karin, M.; Coussens, L. M.; Chen, Y. C.; El-Omar, E. M.; Trinchieri, G.; Dubinett, S. M.; Mao, J. T.; Szabo, E.; Krieg, A.; Weiner, G. J.; Fox, B. A.; Coukos, G.; Wang, E.; Abraham, R. T.; Carbone, M.; Lotze, M. T.
  3. Journal of Immunotherapy. 2010, May; 33(4): 335-351.
  1. 12.   Rapamycin Protects Mice from Staphylococcal Enterotoxin B-Induced Toxic Shock and Blocks Cytokine Release In Vitro and In Vivo
  2. Krakauer, T.; Buckley, M.; Issaq, H. J.; Fox, S. D.
  3. Antimicrobial Agents and Chemotherapy. 2010, Mar; 54(3): 1125-1131.
  1. 13.   A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome
  2. Ranatunga, D.; Hedrich, C. M.; Wang, F. Y.; McVicar, D. W.; Nowak, N.; Joshi, T.; Feigenbaum, L.; Grant, L. R.; Stager, S.; Bream, J. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(40): 17123-17128.
  1. 14.   Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment
  2. Weiss, J. M.; Back, T. C.; Scarzello, A. J.; Subleski, J. J.; Hall, V. L.; Stauffer, J. K.; Chen, X.; Micic, D.; Alderson, K.; Murphy, W. J.; Wiltrout, R. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(46): 19455-19460.
  1. 15.   Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer
  2. Zhang, M. L.; Yao, Z. S.; Dubois, S.; Ju, W.; Muller, J. R.; Waldmann, T. A.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(18): 7513-7518.
  1. 16.   Plasmacytoid dendritic cells mediate oral tolerance
  2. Goubier, A.; Dubois, B.; Gheit, H.; Joubert, G.; Villard-Truc, F.; Asselin-Paturel, C.; Trinchieri, G.; Kaiserlian, D.
  3. Immunity. 2008 29(3): 464-475.
  1. 17.   Nitric oxide is a key component in inflammation-accelerated tumorigenesis
  2. Hussain, S. P.; He, P.; Subleski, J.; Hofseth, L. J.; Trivers, G. E.; Mechanic, L.; Hofseth, A. B.; Bernard, M.; Schwank, J.; Nguyen, G.; Mathe, E.; Djurickovic, D.; Haines, D.; Weiss, J.; Back, T.; Gruys, E.; Laubach, V. E.; Wiltrout, R. H.
  3. Cancer Research. 2008 68(17): 7130-7136.
  1. 18.   HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism
  2. Manches, O.; Munn, D.; Fallahi, A.; Lifson, J.; Chaperot, L.; Plumas, J.; Bhardwaj, N.
  3. Journal of Clinical Investigation. 2008 118(10): 3431-3439.
  1. 19.   Toll-like receptors in inflammation, infection and cancer
  2. Chen, K. Q.; Huang, J.; Gong, W. H.; Iribarren, P.; Dunlop, N. M.; Wang, J. M.
  3. International Immunopharmacology. 2007, Oct; 7(10): 1271-1285.
  1. 20.   Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells
  2. Chen, X.; Howard, O. M. Z.; Oppenheim, J. J.
  3. Journal of Immunology. 2007, May; 178(10): 6123-6129.
  1. 21.   CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques
  2. Hryniewicz, A.; Boasso, A.; Edghill-Smith, Y.; Vaccari, M.; Fuchs, D.; Venzon, D.; Nacsa, J.; Betts, M. R.; Tsai, W. P.; Heraud, J. M.; Beer, B.; Blanset, D.; Chougnet, C.; Lowy, I.; Shearer, G. M.; Franchini, G.
  3. Blood. 2006, Dec; 108(12): 3834-3842.
  1. 22.   Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro
  2. Stone, G. W.; Barzee, S.; Snarsky, V.; Spina, C. A.; Lifson, J. D.; Pillai, V. K. B.; Amara, R. R.; Villinger, F.; Kornbluth, R. S.
  3. Clinical and Vaccine Immunology. 2006, Nov; 13(11): 1223-1230.
  1. 23.   The immunopharmacological properties of transforming growth factor beta
  2. Le, Y. Y.; Yu, X. J.; Ruan, L. F.; Wang, O. M.; Qi, D. F.; Zhu, J. J.; Lu, X. F.; Kong, Y.; Cai, K.; Pang, S. S.; Shi, X. L.; Wang, J. M.
  3. International Immunopharmacology. 2005, DEC; 5(13-14): 1771-1782.
  1. 24.   An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease
  2. Welniak, L. A.; Wang, Z.; Sun, K.; Kuziel, W.; Anver, M. R.; Blazar, B. R.; Murphy, W. J.
  3. Experimental Hematology. 2004 32(3): 318-324.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel